Post-acute Multicomponent Frailty Intervention - Trial NCT05906446

Name: Clinical Trial NCT05906446
Creator: Hebrew SeniorLife
Keywords: Frailty, Multicomponent (Exercise + Protein Supplementation), other, clinical trial

Access comprehensive clinical trial information for NCT05906446 through Pure Global AI's free database. This phase not specified trial is sponsored by Hebrew SeniorLife and is currently Not yet recruiting. The study focuses on Frailty. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT05906446

Not yet recruiting

other

Trial Details

ClinicalTrials.gov • NCT05906446

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Post-acute Multicomponent Frailty Intervention

Feasibility of a Multicomponent Frailty Intervention During Post-acute Rehabilitation in Skilled Nursing Facilities

Study Focus

Disease/Condition

Frailty

Drug/Device/Intervention

Multicomponent (Exercise + Protein Supplementation)

Study Type

Interventional

Intervention Type

other

Sponsor & Location

Primary Sponsor

Hebrew SeniorLife

Timeline & Enrollment

Phase

N/A

Start Date

Jun 01, 2023

End Date

Jun 01, 2024

Enrollment

100 participants

Primary Outcome

Feasibility of the Intervention

Summary

The goal is to test feasibility of a frailty intervention, including exercises and nutritional supplementation.

ICD-10 Classifications

Unattended death

Individuals with autosomal fragile site

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT05906446

Type

Non-Device Trial